BEKhealth uses AI to address the historical underrepresentation of women in clinical trials
March is Women’s History Month, a time to celebrate the contributions of women throughout history and acknowledge the challenges they have faced. One area where women have been historically underserved is in the clinical trial space. Clinical trials are essential for testing new treatments, but historically, women have been underrepresented in medical research, which has led to significant gaps in our understanding of how certain treatments affect women.
Fortunately, there are organizations working to address this issue and improve healthcare outcomes for women. BEKhealth, an AI-powered patient-matching software company, who’s mission is to enhance human health and well-being by significantly increasing patient access to clinical research is one such organization.
By using the BEKhealth platform, healthcare providers can quickly identify matching patients for clinical trials and other healthcare initiatives. The platform can be filtered by various demographics, including race, ethnicity, and gender, allowing providers to connect with all patients and ensure that they are being adequately represented in clinical trials and other healthcare initiatives.
This is particularly important for women, who have historically been underrepresented in clinical trials. According to the Office of Research on Women’s Health, only 19% of clinical trial participants for cardiovascular disease are women, which is troublesome when the leading cause of death in women is, in fact, cardiovascular disease. This is despite the fact that women have different symptoms and risk factors for cardiovascular disease than men, highlighting the importance of including women in clinical trials to ensure that treatments are effective for both genders.
BEKhealth’s platform can help healthcare providers address this issue by allowing them to quickly identify and connect with potential female participants for clinical trials and other healthcare initiatives. By doing so, healthcare providers can help ensure that women are adequately represented in healthcare research and receive treatments that are tailored to their unique needs.
As we draw Women’s History Month to a close, BEKhealth is proud to partner with healthcare providers to improve outcomes and ensure innovative therapies are safe and effective for all patients through clinical trials, including women. We recognize that there is still much work to be done to ensure that all patients, regardless of their background or identity, have access to equitable clinical trials, and we remain committed to driving change in the industry. By continuing to prioritize diversity and inclusion in our platform and our partnerships, we hope to make a positive impact on the healthcare landscape for years to come.
To learn more about how we are working to improve clinical trial outcomes for all patients, visit our website at www.bekhealth.com.
Read More
Tackling Patient Recruitment Challenges from Two Perspectives with AI: TrialGPT and BEKplatform
Artificial intelligence (AI) is revolutionizing the landscape of clinical trials, particularly in the realms of patient recruitment and matching. Innovations like the National Institutes of Health's (NIH) TrialGPT and BEKhealth's AI-powered BEKplatform are at the...
AI and the Art of Patient Engagement: Building Stronger Connections in Clinical Trials
In the dynamic world of clinical trials, keeping patients engaged is no longer just about meeting protocol requirements—it’s about creating meaningful connections. As trials evolve to prioritize patient-centric research, engagement strategies must follow suit. Enter...
AI and Behavioral Profiling: Improving Patient-Matching
Recruiting the right patients for clinical trials has long been one of the most significant hurdles in the clinical research process. Despite the abundance of potential participants, many trials fail to meet their enrollment targets on time, leading to costly delays...
Preventing Patient Dropouts with AI-Based Outreach: How AI Enhances Patient Retention in Clinical Trials
Patient retention is a major challenge in clinical trials. High dropout rates not only increase costs but can also delay results, complicate data analysis, and even jeopardize the success of a study. To address this, artificial intelligence (AI) is emerging as a...